Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PRKCA | P17252 | 4/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.41 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29486060 | 1.00 | TSHR (0.56) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL6558984 | 1.00 | TSHR (0.56) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL27370426 | 1.00 | TSHR (0.56) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL29670983 | 1.00 | TSHR (0.56) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL29670997 | 1.00 | TSHR (0.56) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL27370863 | 1.00 | TSHR (0.56) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL4964017 | 0.94 | TSHR (0.64) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL30690805 | 0.93 | TSHR (0.50) | TSHRHPGDALDH1A1LMNACYP3A4 | |
| SCHEMBL7125959 | 0.89 | TSHR (0.48) | TSHRHPGDALDH1A1CYP3A4ZDHHC7 | |
| SCHEMBL7649106 | 0.89 | TSHR (0.48) | TSHRHPGDALDH1A1CYP3A4ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250155808-A1 | RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | ZEON CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| WO-2024070672-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 日本ゼオン株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2023189969-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3932906-B1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED OBJECT | ADEKA CORP (JP) | 2023-07-12 | — | — | EP | disclosed |
| US-11667609-B2 | Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product | ADEKA CORPORATION (JP) | 2023-06-06 | — | — | US | disclosed |
| US-20220153698-A1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT | ADEKA CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667609-B2 | Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product | H1-0, H1-10, RAD51 | TSHR 4534/4885HPGD 1143/4885ALDH1A1 323/4885 |
| US-20220153698-A1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT | H1-0, H1-10, RAD51 | TSHR 4592/4885HPGD 1263/4885ALDH1A1 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.